Literature DB >> 10352632

Risk factors for resistance to "first-line" antimicrobials among urinary tract isolates of Escherichia coli in children.

U D Allen1, N MacDonald, L Fuite, F Chan, D Stephens.   

Abstract

BACKGROUND: There are increasing concerns regarding antimicrobial resistance in Canada. Data are limited on the prevalence, patterns of resistance and risk factors associated with resistant organisms, including coliforms, in children. This study was done to address these issues as they relate to urinary tract isolates of Escherichia coli in a tertiary care pediatric centre in Ottawa.
METHODS: A surveillance study was conducted from December 1992 to December 1994. Susceptibility testing of urinary tract isolates of E. coli was performed using a panel of antimicrobial agents. A case-control study was also conducted for subjects with isolates resistant to trimethoprim-sulfamethoxazole (T-S), this drug being used a representative "first-line" agent.
RESULTS: A total of 1636 consecutive isolates were obtained from 967 subjects. Of the 1636 isolates, 736 (45.0%) were resistant to ampicillin, 514 (31.4%) were resistant to T-S, 363 (22.2%) were resistant to both ampicillin and T-S, and 27 (1.7%) were resistant to both ampicillin and gentamicin. In the case-control study 274 children with isolates resistant to T-S were matched with 274 children who had T-S-sensitive isolates obtained during the study period or the preceding or subsequent 6 months. Multivariate analyses indicated that subjects who had received antimicrobials for more than 4 weeks in the previous 6 months were about 23 times more likely to have isolates resistant to T-S than were subjects without this risk factor (odds ratio [OR] 23.4, 95% confidence interval [CI] 12.0-47.6). Children with genitourinary tract abnormalities were 2.4 times more likely to have resistant isolates than those without such abnormalities (95% CI 1.2-4.5). Compared with children who had no hospital admissions in the previous year, those with 1 admission in that period were more likely to have resistant isolates (OR 2.3, 95% CI 1.4-7.5), as were those with 2 or more admissions in that period (OR 3.2, 95% CI 1.1-4.8). Compared with children aged 2-6 years, children under 2 years of age were less likely to have resistant isolates (OR 0.3, 95% CI 0.2-0.8).
INTERPRETATION: Selective antimicrobial pressure and multiple admissions to hospital were among the risk factors associated with antimicrobial resistance. The finding of a low but definite level of resistance to both ampicillin and gentamicin is important for the selection of empiric therapy for sepsis in neonates. The role of inexpensive first-line agents in the outpatient treatment and prevention of urinary tract infections requires re-examination, particularly in children who have recently received antimicrobial therapy.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10352632      PMCID: PMC1232603     

Source DB:  PubMed          Journal:  CMAJ        ISSN: 0820-3946            Impact factor:   8.262


  17 in total

Review 1.  Role of the new quinolones in pediatric practice.

Authors:  U B Schaad
Journal:  Pediatr Infect Dis J       Date:  1992-12       Impact factor: 2.129

2.  What can we do about vancomycin-resistant enterococci?

Authors:  B E Murray
Journal:  Clin Infect Dis       Date:  1995-05       Impact factor: 9.079

3.  Frequency and severity of infections in day care.

Authors:  E R Wald; B Dashefsky; C Byers; N Guerra; F Taylor
Journal:  J Pediatr       Date:  1988-04       Impact factor: 4.406

4.  Risk factors for fecal colonization with trimethoprim-resistant and multiresistant Escherichia coli among children in day-care centers in Houston, Texas.

Authors:  R R Reves; M Fong; L K Pickering; A Bartlett; M Alvarez; B E Murray
Journal:  Antimicrob Agents Chemother       Date:  1990-07       Impact factor: 5.191

5.  Double antimicrobial prophylaxis in girls with breakthrough urinary tract infections.

Authors:  E M Smith; J S Elder
Journal:  Urology       Date:  1994-05       Impact factor: 2.649

Review 6.  Penicillin-resistant systemic pneumococcal infections in children: a retrospective case-control study.

Authors:  T Q Tan; E O Mason; S L Kaplan
Journal:  Pediatrics       Date:  1993-12       Impact factor: 7.124

7.  Prophylaxis of urinary tract infection in persons with recent spinal cord injury: a prospective, randomized, double-blind, placebo-controlled study of trimethoprim-sulfamethoxazole.

Authors:  M J Gribble; M L Puterman
Journal:  Am J Med       Date:  1993-08       Impact factor: 4.965

8.  Vancomycin-resistant Enterococcus faecium bacteremia: risk factors for infection.

Authors:  M B Edmond; J F Ober; D L Weinbaum; M A Pfaller; T Hwang; M D Sanford; R P Wenzel
Journal:  Clin Infect Dis       Date:  1995-05       Impact factor: 9.079

9.  The spectrum of antibiotic resistance in human and veterinary isolates of Escherichia coli collected from 1984-86 in northern India.

Authors:  M Singh; M A Chaudhry; J N Yadava; S C Sanyal
Journal:  J Antimicrob Chemother       Date:  1992-02       Impact factor: 5.790

Review 10.  Emergence of resistant Streptococcus pneumoniae: a problem in pediatrics.

Authors:  G H McCracken
Journal:  Pediatr Infect Dis J       Date:  1995-05       Impact factor: 2.129

View more
  43 in total

1.  Wagging the dog: antibiotic use and the emergence of resistance.

Authors:  E Lautenbach; N O Fishman
Journal:  J Gen Intern Med       Date:  1999-10       Impact factor: 5.128

2.  Antibiotic Selection for Urinary Tract Infection: New Microbiologic Considerations.

Authors: 
Journal:  Curr Infect Dis Rep       Date:  1999-10       Impact factor: 3.725

3.  Medical versus surgical management for vesicoureteric reflux: the case for medical management.

Authors:  Armando J Lorenzo
Journal:  Can Urol Assoc J       Date:  2010-08       Impact factor: 1.862

4.  Quality of life in children with vesicoureteral reflux.

Authors:  Darcie A Kiddoo; Faria Ajamian; Ambikaipakan Senthilselvan; Catherine J Morgan; Maury N Pinsk
Journal:  Pediatr Nephrol       Date:  2011-09-30       Impact factor: 3.714

Review 5.  Antibiotic resistance in pediatric urology.

Authors:  Rachel S Edlin; Hillary L Copp
Journal:  Ther Adv Urol       Date:  2014-04

6.  Antibiotic prophylaxis in vesicoureteral reflux: A practice revisited.

Authors:  Jessica Robinson
Journal:  Can Pharm J (Ott)       Date:  2013-03

7.  Endoscopic treatment of vesicoureteral reflux: current practice and the need for multifactorial assessment.

Authors:  Göran Läckgren; Arne Stenberg
Journal:  Ther Adv Urol       Date:  2009-08

8.  Risk factors for antibiotic-resistant Escherichia coli isolated from hospitalized patients with urinary tract infections: a prospective study.

Authors:  A Sotto; C M De Boever ; P Fabbro-Peray; A Gouby; D Sirot; J Jourdan
Journal:  J Clin Microbiol       Date:  2001-02       Impact factor: 5.948

Review 9.  Urinary tract infection in children.

Authors:  James Larcombe
Journal:  BMJ Clin Evid       Date:  2010-02-09

10.  The current evidence based medical management of vesicoureteral reflux: The Sickkids protocol.

Authors:  Sumit Dave; Antoine E Khoury
Journal:  Indian J Urol       Date:  2007-10
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.